Speaker illustration

Doctor Brian Li

Essex Cardiothoracic Centre, Basildon (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

The mortality implications of increasing and decreasing sST2 levels during acute decompensated heart failure

Event: ESC Congress 2024

Topic: Biomarkers

Session: New insights into the role of heart failure biomarkers

Thumbnail

The optimal cut-off threshold of soluble suppressor of tumorigenicity 2 for prognostication in acute decompensated heart failure

Event: Heart Failure 2024

Topic: Biomarkers

Session: Acute heart failure - diagnostic methods 1

Thumbnail

Correlation and utility of the changes in sST2 level at clinician determined decompensation and recompensation

Event: ESC Congress 2023

Topic: Biomarkers

Session: Biomarkers in heart failure: old and new

Thumbnail

Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 2

Thumbnail

Performance of an implanted cardiac device heart failure risk predictor, in a real-world tertiary heart failure clinic

Event: Heart Failure 2019

Topic: Diagnostic Methods

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail